CTSL and infection: Given that human cathepsin L and cruzain share 36% amino-acid identity, and consequently, similar peptide-substrate specificity, we sought to characterize these SMAIs as inhibitors of human cathepsin L, and then evaluate potent inhibitors as potential anti-SARS-CoV-2 agents in models of cellular infection.